{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:27:28Z","timestamp":1792114048852,"version":"4.4.0"},"reference-count":65,"publisher":"Society for Neuroscience","issue":"3","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":231,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["RF1AG066569"],"award-info":[{"award-number":["RF1AG066569"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jneurosci.org"],"crossmark-restriction":true},"short-container-title":["J. Neurosci."],"accepted":{"date-parts":[[2025,11,1]]},"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:p>A previous compound screen identified two molecules with histone deacetylase 6 (HDAC6) inhibitory activity that reduced Alzheimer's disease (AD)-like tau inclusions in a primary rat cortical neuron model seeded with AD brain-derived tau fibrils. Testing here of additional HDAC6-selective inhibitors confirmed that compounds of this type decreased neuronal tau inclusions. Moreover, HDAC6 inhibitors also reduced Parkinson's disease (PD)-like \u03b1-synuclein aggregates in primary neurons seeded with recombinant \u03b1-synuclein fibrils. Knockdown of HDAC6 expression through treatment of seeded neuron cultures with AAV harboring HDAC6-specific shRNA also resulted in a reduction of tau and \u03b1-synuclein inclusions. Multiple compounds were evaluated for their ability to inhibit brain HDAC6 in mice, and ACY-738 was found to effectively inhibit brain HDAC6 activity upon oral dosing. ACY-738 was utilized in an efficacy study in which tau and \u03b1-synuclein pathologies were induced in wild-type mice through intracerebral injections of AD brain-derived tau and \u03b1-synuclein fibrils. Groups of male and female mice first received ACY-738 in drinking water 1\u2005d prior to (preseeding) or 1\u2005week after (postseeding) brain injections of fibrils, followed by continued dosing for an additional 3\u2005months. A control group of fibril-injected mice received water without ACY-738. Immunohistochemical evaluations revealed that ACY-738 administration resulted in significant reductions of tau pathology in both dosing schemes. Moreover, \u03b1-synuclein pathology was significantly reduced in mice with preseeding ACY-738 administration, with a strong trend toward reduction after postseeding dosing. These results suggest that HDAC6 inhibitors have potential for the treatment of AD, PD, and related diseases.<\/jats:p>","DOI":"10.1523\/jneurosci.1092-25.2025","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:50:16Z","timestamp":1764701416000},"page":"e1092252025","update-policy":"https:\/\/doi.org\/10.1523\/jneurosci.crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["HDAC6 Inhibition Reduces Seeded Tau and \u03b1-Synuclein Pathologies in Primary Neuron Cultures and Wild-Type Mice"],"prefix":"10.1523","volume":"46","author":[{"given":"Alex","family":"Crowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevt\u2019her","family":"Hoxha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thallyah","family":"Baffic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt R.","family":"Brunden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"393","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"2026073110051663000_46.3.e1092252025.1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg147"},{"key":"2026073110051663000_46.3.e1092252025.2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00197"},{"key":"2026073110051663000_46.3.e1092252025.3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.3.631"},{"key":"2026073110051663000_46.3.e1092252025.4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192193"},{"key":"2026073110051663000_46.3.e1092252025.5","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3390\/biom13121788","article-title":"Protease-Sensitive and -resistant forms of human and murine alpha-synucleins in distinct brain regions of transgenic mice (M83) expressing the human mutated A53T protein","volume":"13","author":"Betemps","year":"2023","journal-title":"Biomolecules"},{"key":"2026073110051663000_46.3.e1092252025.6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25878"},{"key":"2026073110051663000_46.3.e1092252025.7","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13081"},{"key":"2026073110051663000_46.3.e1092252025.8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1255"},{"key":"2026073110051663000_46.3.e1092252025.9","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1097\/TP.0000000000005042","article-title":"Differential effects of HDAC6 inhibition versus knockout during hepatic ischemia-reperfusion injury highlight importance of HDAC6 C-terminal zinc-finger ubiquitin-binding domain","volume":"108","author":"Concors","year":"2024","journal-title":"Transplantation"},{"key":"2026073110051663000_46.3.e1092252025.10","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds125"},{"key":"2026073110051663000_46.3.e1092252025.11","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt402"},{"key":"2026073110051663000_46.3.e1092252025.12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.436006"},{"key":"2026073110051663000_46.3.e1092252025.13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.010532"},{"key":"2026073110051663000_46.3.e1092252025.14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki312"},{"key":"2026073110051663000_46.3.e1092252025.15","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1023\/B:PHAM.0000048200.98837.6f","article-title":"A novel oral vehicle for poorly soluble HSV-helicase inhibitors: PK\/PD validations","volume":"21","author":"Duan","year":"2004","journal-title":"Pharm Res"},{"key":"2026073110051663000_46.3.e1092252025.16","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23920"},{"key":"2026073110051663000_46.3.e1092252025.17","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1038\/s41598-020-62678-5","article-title":"Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity","volume":"10","author":"Francelle","year":"2020","journal-title":"Sci Rep"},{"key":"2026073110051663000_46.3.e1092252025.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030924"},{"key":"2026073110051663000_46.3.e1092252025.19","doi-asserted-by":"crossref","first-page":"104876","DOI":"10.1016\/j.jbc.2023.104876","article-title":"Identification of small molecules and related targets that modulate tau pathology in a seeded primary neuron model","volume":"299","author":"Gibbons","year":"2023","journal-title":"J Biol Chem"},{"key":"2026073110051663000_46.3.e1092252025.20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160833"},{"key":"2026073110051663000_46.3.e1092252025.21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.209296"},{"key":"2026073110051663000_46.3.e1092252025.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13787-x"},{"key":"2026073110051663000_46.3.e1092252025.23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4172\/2161-0460.1000444","article-title":"The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in Lewy body disorders","volume":"8","author":"Irwin","year":"2018","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"2026073110051663000_46.3.e1092252025.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01465-9"},{"key":"2026073110051663000_46.3.e1092252025.25","doi-asserted-by":"publisher","DOI":"10.1177\/0023677213501659"},{"key":"2026073110051663000_46.3.e1092252025.26","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.207"},{"key":"2026073110051663000_46.3.e1092252025.27","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-802395-2.00025-0"},{"key":"2026073110051663000_46.3.e1092252025.28","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.115.231175"},{"key":"2026073110051663000_46.3.e1092252025.29","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.24.1.1121"},{"key":"2026073110051663000_46.3.e1092252025.30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/cells10010012","article-title":"HDAC6 in diseases of cognition and of neurons","volume":"10","author":"LoPresti","year":"2020","journal-title":"Cells"},{"key":"2026073110051663000_46.3.e1092252025.31","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112457"},{"key":"2026073110051663000_46.3.e1092252025.32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1227157"},{"key":"2026073110051663000_46.3.e1092252025.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.08.053"},{"key":"2026073110051663000_46.3.e1092252025.34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20172158"},{"key":"2026073110051663000_46.3.e1092252025.35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/thno.67410","article-title":"HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity","volume":"12","author":"McAlpin","year":"2022","journal-title":"Theranostics"},{"key":"2026073110051663000_46.3.e1092252025.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.08.044"},{"key":"2026073110051663000_46.3.e1092252025.37","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3951"},{"key":"2026073110051663000_46.3.e1092252025.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2017.10.017"},{"key":"2026073110051663000_46.3.e1092252025.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94923-w"},{"key":"2026073110051663000_46.3.e1092252025.40","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/B978-0-323-98817-9.00029-6","article-title":"Passive tau-based immunotherapy for tauopathies","volume":"196","author":"Panza","year":"2023","journal-title":"Handb Clin Neurol"},{"key":"2026073110051663000_46.3.e1092252025.41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA117.001068"},{"key":"2026073110051663000_46.3.e1092252025.42","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab440"},{"key":"2026073110051663000_46.3.e1092252025.43","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy146"},{"key":"2026073110051663000_46.3.e1092252025.44","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt241"},{"key":"2026073110051663000_46.3.e1092252025.45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"2026073110051663000_46.3.e1092252025.46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jnc.14309","article-title":"Complex neuroprotective and neurotoxic effects of histone deacetylases","volume":"145","author":"Thomas","year":"2018","journal-title":"J Neurochem"},{"key":"2026073110051663000_46.3.e1092252025.47","doi-asserted-by":"publisher","DOI":"10.1038\/srep44102"},{"key":"2026073110051663000_46.3.e1092252025.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19317-4"},{"key":"2026073110051663000_46.3.e1092252025.49","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0238"},{"key":"2026073110051663000_46.3.e1092252025.50","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.molmed.2020.03.012","article-title":"Cell-to-cell transmission of tau and alpha-synuclein","volume":"26","author":"Uemura","year":"2020","journal-title":"Trends Mol Med"},{"key":"2026073110051663000_46.3.e1092252025.51","doi-asserted-by":"crossref","first-page":"624051","DOI":"10.3389\/fneur.2021.624051","article-title":"Antisense oligonucleotide-mediated reduction of HDAC6 does not reduce tau pathology in P301S tau transgenic mice","volume":"12","author":"Valencia","year":"2021","journal-title":"Front Neurol"},{"key":"2026073110051663000_46.3.e1092252025.52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJ-Moa2212948"},{"key":"2026073110051663000_46.3.e1092252025.53","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-061516-045049"},{"key":"2026073110051663000_46.3.e1092252025.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.08.033"},{"key":"2026073110051663000_46.3.e1092252025.55","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2014.143"},{"key":"2026073110051663000_46.3.e1092252025.56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.chembiol.2014.12.015","article-title":"Identification of histone deacetylase inhibitors with benzoylhydrazide scaffold that selectively inhibit class I histone deacetylases","volume":"22","author":"Wang","year":"2015","journal-title":"Chem Biol"},{"key":"2026073110051663000_46.3.e1092252025.57","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(82)90155-1"},{"key":"2026073110051663000_46.3.e1092252025.58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12967-023-04012-x","article-title":"Immunotherapy trials in Parkinson's disease: challenges","volume":"21","author":"Xiao","year":"2023","journal-title":"J Transl Med"},{"key":"2026073110051663000_46.3.e1092252025.59","doi-asserted-by":"crossref","first-page":"e250562","DOI":"10.1001\/jamanetworkopen.2025.0562","article-title":"Sex differences in apolipoprotein E and Alzheimer disease pathology across ancestries","volume":"8","author":"Xu","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026073110051663000_46.3.e1092252025.60","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/alz.12144","article-title":"Correction of microtubule defects within Abeta plaque-associated dystrophic axons results in lowered Abeta release and plaque deposition","volume":"16","author":"Yao","year":"2020","journal-title":"Alzheimers Dement"},{"key":"2026073110051663000_46.3.e1092252025.61","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30375-8"},{"key":"2026073110051663000_46.3.e1092252025.62","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4922-11.2012"},{"key":"2026073110051663000_46.3.e1092252025.63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-018-0291-3","article-title":"A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model","volume":"13","author":"Zhang","year":"2018","journal-title":"Mol Neurodegen"},{"key":"2026073110051663000_46.3.e1092252025.64","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01384-0"},{"key":"2026073110051663000_46.3.e1092252025.65","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01154-06"}],"container-title":["The Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1523\/JNEUROSCI.1092-25.2025","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1523\/JNEUROSCI.1092-25.2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:31:30Z","timestamp":1785522690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jneurosci.org\/lookup\/doi\/10.1523\/JNEUROSCI.1092-25.2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,1,21]]},"published-print":{"date-parts":[[2026,1,21]]}},"alternative-id":["10.1523\/JNEUROSCI.1092-25.2025"],"URL":"https:\/\/doi.org\/10.1523\/jneurosci.1092-25.2025","relation":{},"ISSN":["0270-6474","1529-2401"],"issn-type":[{"value":"0270-6474","type":"print"},{"value":"1529-2401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}